Member Info for Countach

Suggest you take time to see who has been investing from my earlier post. The majority have upped their stake.

Do you think they would all be doing this if progress wasn't looking likely?

Given they went from £2.3m to £4m this year to say not a hope in hell of hitting £8m is a very negative attitude.

The number of users is increasing now.

We may well yet see a good uplift in consumable sales via Creo Europe too now a much larger company has invested with a wider product range.

Plus, I still believe a takeover is on the cards at some point down the line.

It is from a subscription research service.

For me, the important element is core use was up.

It is a small snowball right now but one that will roll ever faster once going.

here is a list of top 24 holders as of jan 2025.

you will note, more of these have added to their holding than reduced.

m&g investment management limited

10.2%

shares 41,083,836

value uk£6.4m

change % 23.5%

portfolio % 0.02%

last reported 02 jan 25

canaccord genuity asset management limited

8.06%

shares 32,450,000

value uk£5.1m

change % -9.89%

portfolio % 0.26%

last reported 02 jan 25

baillie gifford & co.

6.86%

shares 27,614,680

value uk£4.3m

change % 24.9%

portfolio % 0%

last reported 02 jan 25

river global investors llp

5.1%

shares 20,507,371

value uk£3.2m

change % 28.3%

portfolio % 0.21%

last reported 02 jan 25

the creo medical group plc employee benefit trust

4.97%

shares 20,000,000

value uk£3.1m

change % 0%

portfolio % 0%

last reported 02 jan 25

axa investment managers s.a.

4.24%

shares 17,066,642

value uk£2.7m

change % 11.9%

portfolio % 0.01%

last reported 02 jan 25

amati global investors ltd.

3.97%

shares 15,959,536

value uk£2.5m

change % -6.11%

portfolio % 0.6%

last reported 02 jan 25

development bank of wales plc

3.57%

shares 14,376,727

value uk£2.2m

change % 0%

portfolio % 100%

last reported 02 jan 25

canaccord genuity wealth (international) ltd.

2.18%

shares 8,778,151

value uk£1.4m

change % 269,000%

portfolio % 0.03%

last reported 02 jan 25

societe generale group, banking investments

2.06%

shares 8,301,455

value uk£1.3m

change % 0%

portfolio % 0.01%

last reported 02 jan 25

chelverton asset management limited

1.61%

shares 6,484,541

value uk£1.0m

change % 6.87%

portfolio % 0.1%

last reported 02 jan 25

octopus investments limited

1.53%

shares 6,161,500

value uk£962.7k

change % 8.83%

portfolio % 0.07%

last reported 02 jan 25

lgt wealth management uk llp

1.46%

shares 5,866,015

value uk£916.6k

change % -46%

portfolio % 0.06%

last reported 02 jan 25

dowgate capital stockbrokers limited , asset management arm

1.35%

shares 5,450,865

value uk£851.7k

change % 40.7%

portfolio % 0.48%

last reported 02 jan 25

christopher han****

1.2%

role

member of the board of directors

founder

shares 4,824,657

value uk£753.9k

change % 0.17%

portfolio % 0%

last reported 02 jan 25

kevin crofton

1.18%

role

chairman of the board

chairman

shares 4,745,666

value uk£741.5k

change % 0%

portfolio % 0%

last reported 02 jan 25

hbos investment fund managers limited

1.14%

shares 4,573,110

value uk£714.5k

change % 60.2%

portfolio % 0.01%

last reported 02 jan 25

luis collantes

1.1%

shares 4,442,485

value uk£694.1k

change % 0%

portfolio % 0%

last reported 02 jan 25

barclays bank plc, securities investments

1.08%

shares 4,352,700

value uk£680.1k

change % 224%

portfolio % 0%

last reported 02 jan 25

blackrock, inc.

1.06%

shares 4,250,000

value uk£664.1k

change % -20%

portfolio % 0%

last reported 02 jan 25

goldman sachs group, investment banking and securities investments

1.03%

shares 4,149,255

value uk£648.

5p - hardly given the consumables business alone was valued around €70m

Nobody sells £20 notes for 50p

The more of the general public who know of Creo, the more will enquire for relatives who require treatment.

Hiring media consultants costs money. Plenty of younger people are very good at social media. They only need to ID an internal to assist.

Linkdin is old hat, old world now.

Their wider profile is lacking, if you do not hunt for Creo info you would not know they exist.

Given many stocks are down, the rise in AML lately indicates more are expecting a decent trading statement than not.

Not long now to find out.

No doubt there are a lot of people who understand the potential of Creo wishing they were buying in at todays price.

Creo require an employee who is media savy to promote itself better.

C2645,

According to you AML would have had a dozen raises and be 70p now.

Nostradamus you are not.

"SP has passed its bottom level now". It was 14.1p just 2 months ago."

With the 51% sale and value of the other 49% of Creo europe now confirmed it should give SP support.

As another pointed out, Core is basically thrown in for free at current value.

We just await one of a number of triggers now to get the SP heading back up.

MajorOak,

25 years in this game so yes I have had shocks up and down in this time.

Can always be wrong but I cannot see a danger of a downward shock on this one now.

It is not a trial drug so the danger of poor results is not the same.

So far all procedures have gone well that we know of.

Cash is not an issue so long as management do not drag this out for years and years.

I see at least 4 possible catalysts for upward movement.

The only risk I see now is a general loss of interest weighing on the SP.

I do not think NICE approval is the only lever up.

Looking like SP has passed its bottom level now. 🤞 it will now hold & climb

Where is C2645 when you need him.

I'd like a dip to buy on.

Although I suspect his posting have actually helped the SP🤔

For those interested, I have put my trades on AML into a table.

Started in March 2024

Split over 2 accounts. One was traded several times a week, the other every few weeks or months, buying on the lows and usually selling afternoons on good days.

Return since March 2024 has been 79.59%

Trend analysis after close of play today.

The Creo Medical Group Plc stock price fell by -9.83% on the last day (Monday, 17th Feb 2025) from 18.90p to 17.04p. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 21.88% from a day low at 16.00p to a day high of 19.50p. The price has fallen in 6 of the last 10 days and is down by -6.62% for this period. Volume has increased on the last day by 3 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately 51.62p million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at 16.68p is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 19.71% during the next 3 months and, with a 90% probability hold a price between 19.97p and 25.87p at the end of this 3-month period.

Price will creep back up I think.

I have noticed on quite a few trading statements lately, even pretty good ones the SP has dived.

It is the get rich quick mentality, if not a Nvidia type boom in profits it doesn't meet expectations 🤔

Suits me as I have bagged the value shares and quickly been up.

Hey, C2645 & Noveckingood.

Want to borrow a tenner 🤣

Not singing now are you?

And few more at 119 @ 20% 💥

I am still holding but have sold some today at 118

19% too good to turn down.

These forums crack me up, always a vocal group of doom mongers sat trying to sound clever while not making a bean.

That is their loss, AML have been very very good for me.